India  

COVID-19: After Pfizer, Pune-based SII seeks emergency use approval for Covishield vaccine in India

Zee News Monday, 7 December 2020
SII on Sunday applied to the DCGI seeking emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine in the country.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wibbitz Top Stories - Published
News video: FDA Says Pfizer Coronavirus Vaccine Is Safe

FDA Says Pfizer Coronavirus Vaccine Is Safe 01:03

FDA Says Pfizer Coronavirus Vaccine Is Safe. The U.S. Food and Drug Administration published its initial findings concerning the vaccine in briefing documents on Tuesday. [The Pfizer vaccine shows] a favorable safety profile, with no specific safety concerns, FDA Briefing Documents, via...

You Might Like


Related videos from verified sources

Covid-19: India likely to approve AstraZeneca vaccine for emergency use by next week | Oneindia News [Video]

Covid-19: India likely to approve AstraZeneca vaccine for emergency use by next week | Oneindia News

India is likely to approve Oxford-AstraZeneca coronavirus vaccine for emergency use by next week after Serum Institute of India submitted additional data sought by authorities. This could be the first..

Credit: Oneindia     Duration: 01:09Published
FDA Grants Emergency Authorization To Moderna Vaccine [Video]

FDA Grants Emergency Authorization To Moderna Vaccine

On Friday, the Food and Drug Administration granted Moderna's COVID-19 vaccine emergency use authorization. KDKA's Chris Hoffman has the latest.

Credit: KDKA CBS 2 Pittsburgh     Duration: 02:21Published
FDA Authorizes Emergency Use Of Moderna's COVID-19 Vaccine [Video]

FDA Authorizes Emergency Use Of Moderna's COVID-19 Vaccine

The Food and Drug Administration has granted emergency use authorization to the COVID vaccine developed by Moderna.

Credit: CBS 2 New York     Duration: 00:25Published

Related news from verified sources

SII CEO thanks PM Modi for support after seeking emergency authorisation of its Covid vaccine

After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude...
IndiaTimes

Serum Institute seeks emergency use nod for Covishield

Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. "As promised, before the...
Mid-Day

COVID-19: India may get vaccine nod for emergency use by year-end

India is likely to have a COVID-19 vaccine approved for emergency use before December ends as Central Drugs Standard Control Organization's (CDSCO) expert panel...
Mid-Day